US Stock Market Closed

Dashboard

Ampio Pharmaceuticals, Inc. (AMPE)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth
Industry Comparison

H

Management & Equity
Analyst Opinion

H

Leverage & Liquidity

H

Fundamental Variables

Rating Performance

FV Performance

About

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Englewood, CO.

CEO

Michael E. Macaluso

Employees

23

Industry

-

Sector

-

Headquarters

Englewood

Exchange

New York Stock Exchange

Summary Stats

Market Cap

78.1M

Revenue

-

Net Income

-

EPS

$0.00

Price-to-Earnings

-

Price-to-Book

-

Debt-to-Equity

-

News

Analyst Ratings

Price targets projected by 1 analyst

High

$4.00

Average

$4.00

Low

$4.00

Ratings calculated by 1 analyst

Buy

1

Hold

0

Sell

0

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q3 2022

Last Earnings

Missed by -$0.20

Actual

-$0.50 -66.7%

Consensus

-0.3

Report Date

Year Ago

-0.02

Year Ago Change %

Down 2400%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites